Product/Composition:- | Beractant |
---|---|
Strength:- | 25 mg/mL |
Form:- | Intratracheal suspension |
Reference Brands:- | Survanta(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Beractant (Survanta) is a natural bovine lung surfactant used to treat and prevent Respiratory Distress Syndrome (RDS) in premature infants. Available in 25 mg/mL strength, it comes in 4 mL and 8 mL vials. FDA-approved and widely used in US and EU NICUs, it's essential in neonatal care.
Beractant, marketed as Survanta, is a bovine-derived pulmonary surfactant used for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. Each mL contains 25 mg of phospholipids, available in 4 mL (100 mg) and 8 mL (200 mg) single-use vials. Beractant is administered via intratracheal instillation to reduce surface tension in the lungs and improve neonatal respiratory function. Approved by the FDA and widely used in the US and EU, Survanta is a critical product in NICUs worldwide. Trusted by neonatologists, it is a top-choice surfactant for neonatal care and B2B sourcing.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications